Cost-effectiveness Analysis in Clinical Practice
Open Access
- 9 August 1999
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 159 (15) , 1690-1700
- https://doi.org/10.1001/archinte.159.15.1690
Abstract
Review from JAMA Internal Medicine — Cost-effectiveness Analysis in Clinical Practice — The Case of Heart FailureThis publication has 27 references indexed in Scilit:
- Clinical Decision AnalysisMedical Decision Making, 2001
- Cost effectiveness of carvedilol for heart failureThe American Journal of Cardiology, 1999
- Intermittent inotropic therapy in an outpatient setting: A cost-effective therapeutic modality in patients with refractory heart failureAmerican Heart Journal, 1996
- Cost-effectiveness of captopril therapy after myocardial infarctionJournal of the American College of Cardiology, 1995
- Economic outcomes of withdrawal of digoxin therapy in adult patients with stable congestive heart failureJournal of the American College of Cardiology, 1995
- Cost and health implications of cholesterol lowering.Circulation, 1992
- Clinical economics. A guide to the economic analysis of clinical practicesJAMA, 1989
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. Results of a Veterans Administration Cooperative StudySurvey of Anesthesiology, 1987
- The Distinction Between Cost and ChargesAnnals of Internal Medicine, 1982
- Foundations of Cost-Effectiveness Analysis for Health and Medical PracticesNew England Journal of Medicine, 1977